Tech Company Financing Transactions
Valeritas Holdings Funding Round
Advanced Technology Ventures, Tullis Health Investors and private investors participated in a $75.6 million capital raise for Valeritas Holdings. The funding round was announced on 12/31/2012.
Transaction Overview
Company Name
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$75,613,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
750 Route 202 South 600
Bridgewater, NJ 08807
USA
Bridgewater, NJ 08807
USA
Phone
Website
Email Address
Overview
Valeritas (NASDAQ: VLRX) is a medical technologies company serving the fast-growing diabetes market. We designed our first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, to help patients with Type 2 diabetes who require insulin to achieve and maintain their target blood glucose goals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Timberlake
VP - Marketing
Mark Lewis
VP - Operations
Geoffrey Jenkins
VP - R & D
Chris Gregory
VP - Sales
Hokan Ojert
Browse more venture capital transactions:
Prev: 12/31/2012: VerbalizeIt venture capital transaction
Next: 12/31/2012: Mismi venture capital transaction
Share this article
News on VC Transactions
We do our best to document funding rounds that are announced publicly. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs